MedPath

From Controlled Experimental Trial to Everyday Communication: How effective is intensive aphasia therapy under routine clinical conditions?

Not Applicable
Conditions
R47.0
I60
I61
I62
I63
I64
Dysphasia and aphasia
Subarachnoid haemorrhage
Intracerebral haemorrhage
Other nontraumatic intracranial haemorrhage
Registration Number
DRKS00003337
Lead Sponsor
niversitätsklinikum Münster
Brief Summary

Background: Treatment guidelines for aphasia recommend intensive speech and language therapy for chronic (=6 months) aphasia after stroke, but large-scale, class 1 randomised controlled trials on treatment effectiveness are scarce. We aimed to examine whether 3 weeks of intensive speech and language therapy under routine clinical conditions improved verbal communication in daily-life situations in people with chronic aphasia after stroke. Methods: In this multicentre, parallel group, superiority, open-label, blinded-endpoint, randomised controlled trial, patients aged 70 years or younger with aphasia after stroke lasting for 6 months or more were recruited from 19 inpatient or outpatient rehabilitation centres in Germany. An external biostatistician used a computer-generated permuted block randomisation method, stratified by treatment centre, to randomly assign participants to either 3 weeks or more of intensive speech and language therapy (=10 h per week) or 3 weeks deferral of intensive speech and language therapy. The primary endpoint was between-group difference in the change in verbal communication effectiveness in everyday life scenarios (Amsterdam-Nijmegen Everyday Language Test A-scale) from baseline to immediately after 3 weeks of treatment or treatment deferral. All analyses were done using the modified intention-to-treat population (those who received 1 day or more of intensive treatment or treatment deferral). This study is registered with ClinicalTrials.gov, number NCT01540383. Findings: We randomly assigned 158 patients between April 1, 2012, and May 31, 2014. The modified intention-to-treat population comprised 156 patients (78 per group). Verbal communication was significantly improved from baseline to after intensive speech and language treatment (mean difference 2·61 points [SD 4·94]; 95% CI 1·49 to 3·72), but not from baseline to after treatment deferral (-0·03 points [4·04]; -0·94 to 0·88; between-group difference Cohen's d 0·58; p=0·0004). Eight patients had adverse events during therapy or treatment deferral (one car accident [in the control group], two common cold [one patient per group], three gastrointestinal or cardiac symptoms [all intervention group], two recurrent stroke [one in intervention group before initiation of treatment, and one before group assignment had occurred]); all were unrelated to study participation. Interpretation: Three weeks of intensive speech and language therapy significantly enhanced verbal communication in people aged 70 years or younger with chronic aphasia after stroke, providing an effective evidence-based treatment approach in this population. Future studies should examine the minimum treatment intensity required for meaningful treatment effects, and determine whether treatment effects cumulate over repeated intervention periods.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
156
Inclusion Criteria

Presence of aphasia for at least 6 months after non-hemorrhagic or hemorrhagic cortical or subcortico-cortical stroke, native language German, participant's language abilities have to allow the administration of the Aachen Aphasia Test. Minimum level of required language ability defined as a) < 10 errors on the first section of the Token Test subtest of the Aachen Aphasia Test (AAT), b) a score of at least 1 in the AAT subtest 'Spontaneuous Speech' (level 1, communication ability).

Exclusion Criteria

1. Aphasia due to non-vascular etiology; 2. No evidence for aphasia (based on AAT subtests 'Token Test' and 'Written Language'; 3. severe untreated medical conditions which prohibit participation in intensive language therapy; 4. severe vision or hearing problems (uncorrected); 5. participation in another interventional or in intensive language therapy within four weeks before anticipated enrollment.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Therapy-induced mean gain in Amsterdam Nijmegen Everyday Language Test ANELT understandability scores (ANELT A-scale; using the parallel versions ANELT-I and ANELT-II).<br>Performance at baseline is compared to performance immediately and 6 months post 3 weeks of 3 weeks of intensive language therapy. In patients with therapy allowance of > 3 weeks therapy will be continued, and in cases of a total therapy duration of <=5 weeks performance will be re-assessed after therapy completion. <br> <br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath